Hegyesi H, Tóth S, Molnár V, Fülöp KA, Falus A. Endogenous and exogenous histamine influences on angiogenesis related gene expression of mice mammary adenocarcinoma. Inflamm Res. 2007 Apr;56 Suppl 1:S37-8.
Hegyesi H, Colombo L, Pállinger E, Tóth S, Boer K, Molnár V, Falus A. Impact of systemic histamine deficiency on the crosstalk between mammary adenocarcinoma and T cells. J Pharmacol Sci. 2007 Sep;105(1):66-73
Molnár V, Bakos B, Hegyesi H, Falus A. Nem kódoló genom és mikro-RNS-ek: új fejezet a genetika történetében. LAM 2008;18(8-9): 591-597
Andras Falus, Hargita Hegyesi, Susan Darvas, Zoltan Pos, Peter Igaz Edited by András Falus Immunogenomics and Human Disease: Histamine genomics and metabolomics. Wiley& Sons, 2005
Hegyesi Hargita Orvosi biológia Egészségügyi főiskolai jegyzet. IV. fejezet A genomika alapjai 2007
Hargita Hegyesi, Zoltán Pós and Elena Rivera Histamine Biology and Medical Aspects: Edited by András Falus, Nina Grossman Karger 2004
H. Hegyesi, Zs. Darvas, R. Thurmond, A. Falus Histamine Receptors and Signaling. Edited Sandor Damjanovich Aspects of transmembrane Signaling: Springer 2005
Hegyesi Hargita Fejezetek a genomléptékű biológiából és orvostudományból. A tumorképződés és áttétképzés genomikai jellemzése. Szerkesztő: Falus András, Semmelweis kiadó 2006.
Hegyesi Hargita Szép új biológia. Génmanipuláció, génmódosított szervezetek. Szerkesztő: Kovács Tibor, Akkord kiadó 2006
Péter Igaz, Hargita Hegyesi Chapter 3.1 H1, H2, H3, H4 receptors and the potential Hic (intracellular) receptor. Coding genes and gene products- in silico and experimental data.
Tóth Sára, Hegyesi Hargita Bevezetés a humángenetikába. 2.kiadás Semmelweis Kiadó 2006
Hegyesi H, Horvath B, Pallinger E, Pos Z, Molnar V, Falus A. Histamine elevates the expression of Ets-1, a protooncogen in human melanoma cell lines through H2 receptor. FEBS Lett. 2005 Apr 25;579(11): 2475-79
Horvath B, Hegyesi H, Nagy P, Falus A, Schaff Z. Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase-3. Head Neck. 2005 Jul;27(7):585-96.
Pós Z., Sáfrány G., Müller K., Tóth S., Falus A., Hegyesi H. Phenotypic profiling of engineered mouse melanomas with manipulated histamine production identifies two histamine-regulated melanoma progression factors: histamine H2 receptor and rho-C. Cancer. Res. 65. 4458-66. (2005)
Hegyesi H, Darvas Z, Laszlo V, Pos Z, Pallinger E, Hirsvhberg K, Kovacs P, Falus A. Retinoic acid enhances histamine content and H1 receptor expression in human neuroblastoma cell line Paju. Anticancer Res. 2004 May-Jun;24(3): 1657-63
Burian K, Hegyesi H, Buzas E, EndreszV, Kis Z, Falus A, Gonczol E. Chlamydophila (Clamydia) pneumoniae induces histidine decarboxylase production in the mouse lung. Immunol Lett. 2003 Oct 31; 89(2-3): 229-36
Darvas Z, Sakurai E, Schwelberger HG, Hegyesi H, Rivera E, Othsu H, Watanabe T, Pallinger E, Falus A. Autonomous histamine metabolism in human melanoma cells. Melanoma Res. 2003 Jun;13(3): 239-46
Borbas T, Hegyesi H. [Huntington chorea: genetics and biochemistry, diagnosis and therapy] Acta Pharm Hung. 2002;72(2):127-36.
Keresztury L, Laszik A, Hegyesi H, Falus A. DNA profiling by detection of repetitive nucleotide sequences on human chromosome 6. Acta Biol Hung. 2002;53(4):495-8.
Holub MC, Hegyesi H, Igaz P, Polgár A, Toth S, Falus A. Soluble interleukin-6 receptor enhanced by oncostatin M induces major changes in gene expression profile of human hepatoma cells. Immunol Lett. 2002 Jun 3;82(1-2):79-84.
Lazar-Molnar E, Hegyesi H, Pallinger E, Kovacs P, Toth S, Fitzsimons C, Cricco G, Martin G, Bergoc R, Darvas Z, Rivera ES, Falus A. Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin-6. Eur J Clin Invest. 2002 Oct;32(10):743-9.
Szincsak N, Hegyesi H, Hunyadi J, Falus A, Juhasz I. Different h2 receptor antihistamines dissimilarly retard the growth of xenografted human melanoma cells in immunodeficient mice. Cell Biol Int. 2002;26(9):833-6.
Szincsak N, Hegyesi H, Hunyadi J, Martin G, Lazar-Molnar E, Kovacs P, Rivera E, Falus A, Juhasz I. Cimetidine and a tamoxifen derivate reduce tumour formation in SCID mice xenotransplanted with a human melanoma cell line Melanoma Res. 2002 Jun;12(3):231-40.
Falus A, Hegyesi H, Lazar-Molnar E, Pos Z, Laszlo V, Darvas Z. Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation Trends Immunol. 2001 Dec;22(12):648-52.
Hegyesi H, Somlai B, Varga VL, Toth G, Kovacs P, Molnar EL, Laszlo V, Karpati S, Rivera E, Falus A, Darvas Z. Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides. J Invest Dermatol. 2001 Jul;117(1):151-3.
Laszlo V, Rothe G, Hegyesi H, Szeberenyi JB, Orso E, Schmitz G, Falus A. Increased histidine decarboxylase expression during in vitro monocyte maturation; a possible role of endogenously synthesised histamine in monocyte/macrophage differentiation Inflamm Res. 2001 Aug;50(8):428-34.
Molnar EL, Cricco G, Martin G, Darvas Z, Hegyesi H, Fitzsimons C, Bergoc R, Falus A, Rivera E. Histamine as a potential autocrine regulator of melanoma. Inflamm Res. 2001 Apr;50 Suppl 2:S102-3
Darvas Z, Sakurai E, Hegyesi H, Otsu H, Watanabe T, Falus A. Turnover of histamine in human melanoma cell lines. Inflamm Res. 2000 Apr;49 Suppl 1:S70-1
Fulop AK, Hegyesi H. Non-conventional locations of hormone receptors (binding sites). A review. Acta Biol Hung. 1999;50(4):343-54. Review.
Gadó K, Domján G, Hegyesi H, Falus A. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma. Cell Biol Int. 2000;24(4):195-209. Review.
Haak-Frendscho M, Darvas Z, Hegyesi H, Karpati S, Hoffman RL, Laszlo V, Bencsath M, Szalai C, Furesz J, Timar J, Bata-Csorgo Z, Szabad G, Pivarcsi A Pallinger E, Kemeny L, Horvath A, Dobozy A, Falus A. Histidine decarboxylase expression in human melanoma J Invest Dermatol. 2000 Sep;115(3):345-52.
Hegyesi H, Kovacs P, Falus A, Csaba G. Presence and localization of histidine decarboxylase enzyme (HDC) and histamine Tetrahymena pyriformis Cell Biol Int. 1998;22(7-8):493-7.
Hegyesi H, Szalai C, Falus A, Csaba G. The histidine decarboxylase (HDC) gene of Tetrahymena pyriformis is similar to the mammalian one. A study of HDC expression. Biosci Rep. 1999 Apr;19(2):73-9.
Horvath B, Heninger E, Hegyesi H, Lazar E, Radvany Z, Szalai C, Darvas Z, Falus A. Reciprocal inhibitory interactions between interferon gamma and histamine in melanoma. Inflamm Res. 2000 Apr;49 Suppl 1:S27-8.
Heninger E, Falus A, Darvas Z, Szalai C, Zsinko M, Pos Z, Hegyesi H. Both interferon (IFN)alpha and IFNgamma inhibit histidine decarboxylase expression in the HT168 human melanoma cell line. Inflamm Res. 2000 Aug;49(8):393-7.
Kovacs P, Hegyesi H, Kohidai L, Nemes P, Csaba G. Effect of C2 ceramide on the inositol phospholipid metabolism (uptake of 32P, 3H-serine and 3H-palmitic acid) and apoptosis-related morphological changes in Tetrahymena Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 122(2):215-24. 1999 Feb;
Lazar-Molnar E, Hegyesi H, Toth S, Falus A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine. 2000 Jun;12(6):547-54. Review
Laszlo V, Stohr J, Hegyesi H, Rothe G, Orso E, Falus A, Schmitz G. Increase of histidine decarboxylase in human monocytes during macrophage colony stimulating factor induced in vitro phagocytic differentiation. Inflamm Res. 1999 Apr;48 Suppl 1:S85-6
Molnar EL, Hegyesi H, Toth S, Darvas Z, Laszlo V, Szalai C, Falus A. Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine. Semin Cancer Biol. 2000 Feb;10(1):25-8. Review.
Falus A, Laszlo V, Radvany Z, Hegyesi H, Kiss B, Bencsath M, Darvas Z. Histidine decarboxylase and intracellular histamine in melanoma cells and in a T cell line Inflamm Res. 1997 Mar;46 Suppl 1:S51-2.
Hegyesi H, Csaba G. Time- and concentration-dependence of the growth-promoting activity of insulin and histamine in Tetrahymena. Application of the MTT-method for the determination of cell proliferation in a protozoan model. Cell Biol Int. 1997 May;21(5):289-93.
Csaba G, Hegyesi H. Immunocytochemical verification of the insulin receptor's specificity in the nuclear envelope of Tetrahymena. Comparison with receptors of the plasma membrane. Biosci Rep. 1994 Feb;14(1):25-31.
Hegyesi H, Csaba G. Effect of permanent starvation on the insulin receptors of the nuclear envelope of Tetrahymena Acta Microbiol Immunol Hung. 1994;41(3):241-5.
Hegyesi H, Csaba G. Change in insulin binding capacity of plasma membrane and nuclear envelope of Tetrahymena following a single long-term pretreatment and several short-term pretreatments (imprinting) with insulin. Cytobios. 1994;79(318):189-94.
Hegyesi H, Csaba G. A calcium-dependent protein kinase is present in tetrahymena. Cell Biochem Funct. 1994 Sep;12(3):221-6.
Kovacs P, Hegyesi H, Csaba G. Effect of vanadate and ouabain on insulin binding and insulin imprinting in Tetrahymena. \Cell Biochem Funct. 1992 Mar;10(1) 31-4.
Csaba G, Hegyesi H, Torok O. Impact of serum concentration of the medium and fasting on the imprintability of the insulin receptors of Chang liver cells. Acta Physiol Hung. 1992;79(2):213-7.
Csaba G, Hegyesi H. Specificity of insulin binding by plasma and nuclear membrane receptors in Tetrahymena: similarities and dissimilarities at the two levels. Cytobios. 1992;70(282-283):153-8.
Csaba G, Hegyesi H, Torok O. Impact of combined hormonal pretreatment (insulin+TSH) on the imprinting of hormonesadministered in combination to Chinese hamster ovary cell culture. Acta Physiol Hung. 1992;79(1):65-72.
Hegyesi H, Kovacs P, Csaba G. Chloroquine inhibits the insulin binding and the imprinting of nuclear envelope in Tetrahymena Acta Microbiol Hung. \1992;39(3-4) 289-93.
Hegyesi H, Csaba G. Specific insulin binding by, and imprintability of, the nuclear membrane of Tetrahymena Cytobios. 1992;72(290-291):153-7.
Hegyesi H, Csaba G. Effect of pretreatments (imprinting) with different concentrations of insulin on insulin bindingof nuclear envelope and plasma membrane in Tetrahymena. Cytobios. 1992;72(290-291):191-6.
Publikált absztraktok:
Benedek A., Hegyesi H., Kis E., Lumniczky K. és Sáfrány G. A kis dózisok biológiai hatásai: génexpressziós változások besugárzott és bystander sejtekben. Magyar Higiénikusok Társasága XXXVIII. Vándorgyűlés, Balatonvilágos, 32.oldal 2008 szept. 30-okt. 2,
Hegyesi H., Benedek A., Kis E., Lumniczky K. és Sáfrány G. Kis dózisú ionizáló sugárzás hatására bekövetkező gén-expressziós változások közvetlen sugársérülést szenvedett és bystander sejtekben. Népegészségügyi Tudományos Társaság XVI. Nagygyűlése, 2008. április 17-19. Pécs; Magyar Epidemiológia, V. S86. 2008
Pos Z, Wiener Z, Pocza P, Racz M, Toth S, Darvas Z, Molnar V, Hegyesi H, Falus A. Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma. Cancer Res. 15;68(6):1997-2005. 2008 Mar
A. Dalloul Hegyesi H. Apor P. Csende Z. Racz L. Vaczi M. Tihanyi J. Impact of repeated bouts of eccentric exercise on myogenic gene expression.Eur J Appl Physiol. 101(4):427-36. 2007 Nov
